Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relevance of Plasma PCSK9 Concentration as a Biomarker in Acute Coronary Syndrome.

NCT01109706 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01109706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01109706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relevance of Plasma PCSK9 Concentration as a Biomarker in Acute Coronary Syndrome.
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
February 13, 2011
Completion date
July 16, 2015
Enrollment
175 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome